Inventor · disambiguated record
Scott K. Thompson
Also filed as: THOMPSON SCOTT · THOMPSON SCOTT K · THOMPSON SCOTT KEVIN
40 granted patents·28 pending applications·381 citations·filing 1995–2024
98Inventor score
Files withASANA BIOSCIENCES LLC26SMITHKLINE BEECHAM CORP18ENDO PHARMACEUTICALS INC3CURADEV PHARMA PRIVATE LTD2FRAZEE JAMES S2
Top patents by PatentIndex Score
68 records- 0194US7304082B21,2,4-triazole derivatives, compositions, process of making and methods of useSMITHKLINE BEECHAM CORP·Filed 2005·Granted Dec 4, 2007·30 cites·9 claims
- 0293US5684032ACompoundsSMITHKLINE BEECHAM CORP·Filed 1995·Granted Nov 4, 1997·73 cites·13 claims
- 0392US6331542B1Protease inhibitorsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Dec 18, 2001·44 cites·13 claims
- 0490US11103491B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2020·Granted Aug 31, 2021·2 cites·12 claims
- 0589US11339169B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2020·Granted May 24, 2022·2 cites·39 claims
- 0689US9908879B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2016·Granted Mar 6, 2018·5 cites·43 claims
- 0786US9944637B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2014·Granted Apr 17, 2018·5 cites·30 claims
- 0885US10174039B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2017·Granted Jan 8, 2019·4 cites·39 claims
- 0985US2024391925A1P2x3 and/or p2x2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1084US10751332B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Aug 25, 2020·2 cites·7 claims
- 1184US7405209B2Protease inhibitorsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Jul 29, 2008·2 cites·16 claims
- 1283US10316039B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2018·Granted Jun 11, 2019·2 cites·3 claims
- 1383US8685418B2CyclohexylaminesENDO PHARMACEUTICALS INC·Filed 2012·Granted Apr 1, 2014·6 cites·1 claims
- 1483US7247748B2Amide compounds and methods of using the sameSMITHKLINE CORP·Filed 2003·Granted Jul 24, 2007·24 cites·27 claims
- 1583US5998470AProtease inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Dec 7, 1999·38 cites·11 claims
- 1683US2023219954A1P2x3 and/or p2x2/3 compounds and methodsABS DEV 1 INC·Filed 2023·Application pending·0 cites
- 1782US10471051B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2017·Granted Nov 12, 2019·3 cites·38 claims
- 1882US9896445B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Feb 20, 2018·3 cites·27 claims
- 1981US10611768B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2018·Granted Apr 7, 2020·2 cites·43 claims
- 2081US8440662B2Substituted quinazoline and pyrido-pyrimidine derivativesSMITH ROGER ASTBURY·Filed 2011·Granted May 14, 2013·9 cites·46 claims
- 2181US7560586B2Acid and ester compounds and methods of using the sameSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jul 14, 2009·20 cites·27 claims
- 2281US7365085B2Compounds and methodsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Apr 29, 2008·25 cites·36 claims
- 2380US9499495B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2014·Granted Nov 22, 2016·4 cites·43 claims
- 2480US6284777B1Carbohydrazide protease inhibitorsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Sep 4, 2001·10 cites·13 claims
- 2579US10544145B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2019·Granted Jan 28, 2020·1 cites·17 claims
- 2678US10590127B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2018·Granted Mar 17, 2020·1 cites·32 claims
- 2776US12077543B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2022·Granted Sep 3, 2024·0 cites·2 claims
- 2876US11925629B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2021·Granted Mar 12, 2024·0 cites·14 claims
- 2976US6232342B1Protease inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted May 15, 2001·26 cites·14 claims
- 3075US11685736B2P2X3 and/or P2X2/3 compounds and methodsASANA BIOSCIENCES LLC·Filed 2019·Granted Jun 27, 2023·0 cites·44 claims
- 3172US2021113578A1Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathwaysASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 3271US5955492ACarboxylic acid indole inhibitors of chemokinesSMITHKLINE BEECHAM CORP·Filed 1997·Granted Sep 21, 1999·32 cites·13 claims
- 3370US10912779B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2019·Granted Feb 9, 2021·0 cites·23 claims
- 3466US7323494B2Compounds and methodsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 29, 2008·4 cites·26 claims
- 3559US9815811B2Inhibitors of the kynurenine pathwayCURADEV PHARMA PRIVATE LTD·Filed 2014·Granted Nov 14, 2017·1 cites·10 claims
- 3659US9115092B2Substituted quinazoline and pyrido-pyrimidine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Aug 25, 2015·0 cites·12 claims
- 3758US10226468B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2017·Granted Mar 12, 2019·0 cites·35 claims
- 3858US9757382B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2016·Granted Sep 12, 2017·0 cites·25 claims
- 3957US8865741B2Aminoindane compounds and use thereof in treating painTHOMPSON SCOTT KEVIN·Filed 2012·Granted Oct 21, 2014·1 cites·55 claims
- 4057US2014073782A1Substituted Quinazoline and Pyrido-Pyrimidine DerivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4156US7563784B2Protease inhibitorsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Jul 21, 2009·0 cites·7 claims
- 4256US2013190492A1Substituted quinazoline and pyrido-pyrimidine derivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4353US9180115B2CyclohexylaminesASANA BIOSCIENCES LLC·Filed 2014·Granted Nov 10, 2015·0 cites·18 claims
- 4452US2016222014A1Compounds for regulating fak and/or src pathwaysASANA BIOSCIENCES LLC·Filed 2014·Application pending·0 cites
- 4551US2005004116A1Triazole inhibitors of type 2 methionine aminopeptidaseSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 4650US2004002487A1Protease inhibitorsFiled 2003·Application pending·0 cites
- 4749US9199975B2Biaryl imidazole derivatives for regulating CYP17ASANA BIOSCIENCES LLC·Filed 2012·Granted Dec 1, 2015·0 cites·18 claims
- 4849US2004229863A1Protease inhibitorsSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 4949US2010311989A1Process for the preparation of renin inhibitorsHAMMOND MARLYS·Filed 2008·Application pending·0 cites
- 5048US2005143578A1Compounds and methodsSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott K. Thompson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →